Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients

Publisher： Karger

E-ISSN： 1421-9867|78|4|180-186

ISSN： 0012-2823

Source： Digestion, Vol.78, Iss.4, 2008-12, pp. : 180-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rectal Hypersensitivity Reduced by Acupoint TENS in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study

By Xiao Wen-Bin   Liu Yu-Lan  

Digestive Diseases and Sciences, Vol. 49, Iss. 2, 2004-02 ,pp. : 312-319

Springer Publishing Company

Access to resources Recommend Favorite

Leaky Gut in Patients with Diarrhea-Predominant Irritable Bowel Syndrome and Inactive Ulcerative Colitis

By  

Digestion, Vol. 85, Iss. 1, 2011-12 ,pp. : 40-46

Karger

Access to resources Recommend Favorite

A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome

By  

Digestion, Vol. 77, Iss. 3-4, 2008-06 ,pp. : 225-235

Karger

Access to resources Recommend Favorite

The Effect of Inactivated Lactobacillus LB Fermented Culture Medium on Symptom Severity: Observational Investigation in 297 Patients with Diarrhea-Predominant Irritable Bowel Syndrome

By  

Digestive Diseases, Vol. 29, Iss. 6, 2011-12 ,pp. : 588-591

Karger

Access to resources Recommend Favorite

Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS) May Have Elevated Serotonin Concentrations in Colonic Mucosa as Compared with Diarrhea-Predominant Patients and Subjects with Normal Bowel Habits

By  

Digestion, Vol. 63, Iss. 3, 2001-05 ,pp. : 188-194

Karger

Access to resources Recommend Favorite